Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis.

In this study, we identified 3 paclitaxel resistance relevant IFs and their inhibitors, which offers essential molecular basis for paclitaxel resistance and beneficial guidance for the combination of paclitaxel in clinical TNBC therapy.